The Aldebert Autopsies · Autopsy No. 14

Proterra: The EV Manufacturer That Ran Three Businesses On One Cash Pool

Proterra was founded in Golden, Colorado in 2004 as an electric transit bus company. Nineteen years later, on August 7, 2023, it filed Chapter 11 in the District of Delaware. Assets and liabilities each fell in the $500 million to $1 billion range. Market cap on the filing day was $362 million, down from a $1.6 billion valuation at its January 2021 SPAC listing. 2022 revenue was $309.4 million. 2022 net loss was $238 million. The business was losing 77 cents on every revenue dollar and running three separate business lines simultaneously on the same cash pool. This is what actually killed the biggest EV bus maker in the United States.

Proterra did not die from the electric bus market. The electric bus market exists. It is growing. Blue Bird continues to sell EV school buses. New Flyer continues to sell EV transit buses. Thomas Built, formerly a Proterra powertrain customer, kept producing EV school buses after Proterra filed and continues to today.

Proterra died from trying to be three companies at the same time on the capital pool of one company. A bus manufacturer. A battery and powertrain supplier. And a charging infrastructure operator. Each business line had its own capital cycle. Each had its own working capital requirement. Each had its own path to profitability that was five to ten years out. And all three shared one cash reserve, funded by venture capital before 2021 and by the $640 million net proceeds of a SPAC merger after.

The verdict. Proterra ran the Two Cancers spiral in accelerated form because the fuel was not operating profit. The fuel was public-market patience. When public markets tightened in 2022 and 2023, Cancer 2 hit the Working Capital Gap all at once, and there was no operating cash flow to close it. Three business lines could not all be funded from one cash pool that was no longer being refilled. The Chapter 11 filing was not a shock. The doctrine had been reading the ending since roughly late 2022, when the quarterly cash burn passed the point at which the market cap could plausibly support another equity raise. What Gareth Joyce called market and macroeconomic headwinds is what the doctrine calls Cancer 2 arriving without warning to a business whose Cancer 1 had never been sized correctly.

The spiral in the wild

Proterra ran the spiral at $1.6 billion scale in 31 months. The January 2021 SPAC netted $640 million of new capital. Every quarter of 2021, 2022, and 2023 burned a portion of that capital across three unprofitable business lines. Cancer 1 was the fixed R&D and manufacturing infrastructure obligation the company had committed to. Cancer 2 was the widening Working Capital Gap as the three business lines all reached scale without any of them reaching profit. When the public markets refused to fund another round, both cancers arrived simultaneously.

Read The Two Cancers for the mechanism at the $2 million to $8 million SMB dollar scale where most of the diagnostic record actually sits.

The Rise

Dale Hill founded Proterra in Golden, Colorado in 2004. Hill was a mechanical engineer with a background in heavy vehicle design and a thesis that electric drivetrains would eventually replace diesel in transit buses. Transit buses were an attractive target for electrification because the routes were fixed, the depot charging was manageable, the total daily miles were predictable, and municipal buyers were willing to subsidize cleaner air. The problem in 2004 was not the demand curve. The problem was that battery technology was not ready and the cost per bus was three times the diesel alternative.

Hill spent the first decade of Proterra's existence building bus prototypes, cycling through battery chemistries, and pursuing municipal transit authority contracts one at a time. The company relocated to Greenville, South Carolina in 2010 to be closer to bus manufacturing labor and supply chains. The first commercial deliveries were to Foothill Transit in California in 2010 and 2011. Every early customer was a public transit agency. Every early sale was heavily subsidized by federal and state grants.

Between 2010 and 2020 Proterra raised approximately $682 million in venture capital across multiple rounds. Backers included Daimler and a series of climate-focused funds and strategic investors. The theory of the deal was straightforward. Battery costs would fall on the same curve consumer electronics had followed. Grid infrastructure would develop. Federal policy would eventually mandate transit electrification. Whoever had the manufacturing scale and the powertrain intellectual property when that policy landed would own the category. Proterra positioned itself as that company.

By 2019 Proterra was operating three business lines. Proterra Transit built the ZX5 electric bus. Proterra Powered supplied battery packs and drivetrains to other vehicle manufacturers including Thomas Built Buses and Freightliner Custom Chassis. Proterra Energy built and operated charging infrastructure. Each of the three lines had its own product roadmap, its own capital plan, and its own path to breakeven that management projected somewhere between 2024 and 2027. Each was pre-profit. Each was expected to grow into a large business at some future date. All three shared one balance sheet.

In January 2021 Proterra went public through a reverse merger with ArcLight Clean Transition Corporation, a SPAC. The deal valued Proterra at $1.6 billion and netted the company $640 million in cash. Nasdaq: PTRA started trading immediately. The 2021 timing was almost perfect. The Bipartisan Infrastructure Law passed in November 2021 and included substantial EV bus procurement funding. The Inflation Reduction Act passed in August 2022 and added domestic battery manufacturing incentives. Proterra was positioned to benefit from both.

Then the arithmetic caught up with the story.

The Fracture

2022 was the year the P&L stopped being a story about growth and started being a diagnosis about cash. Revenue reached $309.4 million, up meaningfully from prior years. Net loss for the same year was $238 million. The business was losing 77 cents on every revenue dollar. Every bus that shipped, every battery pack Proterra Powered sold, every charging station Proterra Energy installed was a cash consumer, not a cash producer. The revenue growth the story required was actually accelerating the cash burn.

This is the specific arithmetic that separates a scale-up manufacturing business from a going-concern manufacturing business. In a going concern, every incremental unit of revenue produces incremental operating margin that funds the next unit. Working Capital Required grows with revenue, but Working Capital Actual grows too because the business is generating cash. In a scale-up, incremental revenue costs incremental cash. Working Capital Required grows with revenue, but Working Capital Actual shrinks because the business is losing money on every unit. The Cash Conversion Cycle appears to work on paper because receivables are being collected. It does not work in aggregate because the operating loss on the unit is larger than the working capital the unit turns.

The doctrine has a name for this condition. It is a Working Capital Gap that widens with every dollar of revenue. Growth does not close it. Growth widens it. Every strategic decision Proterra made in 2021 and 2022, from expanding the South Carolina battery manufacturing to adding contracts on the Powered and Energy side, widened the Gap. The SPAC proceeds were not working capital in the doctrine sense. They were a one-time equity raise being consumed to fund three parallel operating losses.

By the middle of 2022 the public markets had shifted. Interest rates were rising. Growth-stage EV companies were being repriced. Proterra's stock, which had traded above $12 at the SPAC-merger close, fell below $5 by summer 2022 and below $2 by early 2023. The market cap that had been $1.6 billion at listing was $362 million on the day of the bankruptcy filing. Every quarter Proterra needed to raise fresh capital to continue funding three business lines. Every quarter the public markets became less willing to provide it.

The Three-Business Problem

The specific mistake Proterra made, and the reason this Autopsy sits in the manufacturing pillar, is that the company ran three separate businesses on one capital pool without giving any of them a chance to prove its own unit economics before the next one was funded.

Proterra Transit was a bus manufacturer. Bus manufacturing is a low-turn, capital-intensive business. A transit bus takes 12 to 18 months from order to delivery. Working Capital Capacity for a bus manufacturer is enormous because materials and labor are committed to a bus 12 months before payment lands. A bus manufacturer needs to hold Working Capital Actual equal to at least six to nine months of production burn just to bridge from committing to a bus to collecting for it. Proterra Transit's Working Capital Required was measured in hundreds of millions of dollars against a business that was not yet at operating breakeven.

Proterra Powered was a battery pack and drivetrain supplier. Battery pack supply is a different economic model. It sells to other original equipment manufacturers. It requires long design-in cycles, multi-year contracts, and volume commitments before pricing works. Working Capital Required for a battery supplier is different from bus manufacturing but no less demanding. Proterra Powered was signing contracts through 2020 and 2021 that would not produce meaningful revenue until 2023 and 2024. All the design-in and manufacturing setup cost landed on the balance sheet immediately.

Proterra Energy was a charging infrastructure business. Charging infrastructure is a real estate, permitting, and construction business dressed up as clean tech. Working Capital Required for a charging operator is dominated by the capital cost of the charging stations themselves, plus the long-cycle permitting and utility interconnection work. Revenue lags installation by 12 to 24 months while the charging stations reach utilization. Proterra Energy was investing in installations in 2020 and 2021 that would not produce meaningful revenue until 2024 or later.

Each of the three businesses had a defensible thesis in isolation. Each of the three had a defensible path to breakeven at scale. What none of the three had was a source of operating cash flow to fund the other two while all three simultaneously chased scale. Public market patience was the intended source of that cash flow. When the public markets tightened, all three business lines discovered at the same time that none of them was independently self-funding.

The Doctrine Overlay

Read the Proterra bankruptcy against the doctrine and the pattern is not a surprise. It is the exact configuration the Two Cancers doctrine predicts for scale-up manufacturing companies operating on external capital instead of operating profit.

Cancer 1 was unmeasured. Debt service in a traditional operating business is interest and principal on notes and lines of credit. In a pre-profit company operating on venture capital and SPAC proceeds, Layer 1 of MMP takes a different shape. It is the fixed monthly R&D burn plus the fixed monthly manufacturing infrastructure cost plus the fixed cost of running three separate business lines with three separate management teams. Every one of those obligations is due whether the business hits its revenue plan or not. Proterra did not lack the P&L visibility to see the numbers. Proterra lacked the doctrine framework to size Layer 1 correctly against a Layer 2 that was pre-existing venture capital and not operating margin. In a normal SMB, Layer 1 is $6,900 a month in debt service on a $340,000 note. In Proterra, Layer 1 was tens of millions a quarter in fixed operating obligations against a Layer 2 that was a finite equity balance being consumed. The size was different. The mechanism was identical.

Cancer 2 accelerated as revenue grew. This is the counterintuitive piece for owners who have never seen it. Every dollar of Proterra revenue in 2022 widened the Working Capital Gap because the operating loss on the revenue was larger than the working capital the revenue turned. Growth was the problem, not the solution. A $4 million contractor with a $2,400 monthly shortfall widens the Gap by roughly $28,800 a year. Proterra widened the Gap by hundreds of millions in 2022 alone. Same mechanism at different scales.

The refill-with-new-capital move failed the same way SMB refill-with-new-debt fails. In an SMB the owner takes a new line of credit or an SBA loan to refill working capital. Layer 1 climbs and the shortfall widens. In Proterra the company was expected to raise new equity every 12 to 18 months to refill the cash pool. Layer 1 did not literally climb because the equity was not debt, but Layer 2 was being consumed at a rate that required continuous refilling. When the public markets refused to provide the next refill in 2023, the spiral hit terminal velocity. There was no operating profit to fall back on because none of the three business lines had ever reached operating profit.

The retreat sequence was too late. Between June 2022 and August 2023 Proterra took a series of measures to reduce burn. Restructuring charges. Layoffs. Announced consolidation of bus and battery manufacturing to a single South Carolina facility. Each measure was defensible. None of them arrived in time. By the time the company was reducing Layer 1 obligations, Layer 2 was already too thin to absorb the transition costs. The doctrine has a name for this too. It is the point at which reversal is no longer possible because the working capital reserve is smaller than the cost of stopping the bleeding.

The Intervention That Would Have Worked

Every Autopsy in the archive is a business where an earlier intervention would have changed the outcome. Proterra is no different. The intervention that would have worked was a doctrine question that nobody in the boardroom asked.

Which of the three business lines is closest to independently self-funding, and can that one be separated financially from the other two so its Working Capital Actual is protected from the burn of the other two.

If the answer had been Proterra Transit, then Powered and Energy should have been sold, spun out, or wound down in 2021 while the SPAC proceeds were still meaningful. Transit could have consumed the full remaining cash pool, reached scale, and closed the operating loss on a single business line. It might have survived.

If the answer had been Proterra Powered, then Transit and Energy should have been sold or spun out in 2021. Powered would have been a battery supplier at scale by 2024 with the IRA tailwind. It might have survived.

If the answer had been Proterra Energy, then Transit and Powered should have been sold or spun out in 2021 and Energy would have become a charging network operator with the Bipartisan Infrastructure Law tailwind. It might have survived.

The doctrine question forces a choice. Choose one Working Capital pool and protect it. Do not run three Working Capital pools on the same cash reserve. The company that tried to do that with a $2 billion capital pool between 2015 and 2021 was Katerra, which is Autopsy No. 13. The company that tried to do it with a $1.6 billion capital pool between 2021 and 2023 was Proterra, which is Autopsy No. 14. Same mistake at different scales in different industries. Same terminal outcome.

In the post-bankruptcy period, exactly this split happened. Volvo bought Proterra Powered. Phoenix Motor bought Proterra Transit. Marmon Holdings bought Proterra Energy assets. Three separate buyers acquired three separate business lines because that is how the three business lines should have been capitalized from the beginning. Each buyer will run its acquired business as a standalone. Each has a plausible path to profitability. The businesses were viable. The combination was not.

The Lesson For SMB Owners

Most SMB owners reading this Autopsy are not running a $1.6 billion venture-backed EV manufacturer. Most are running a $2 million to $8 million business with a single product or service line, one or two locations, and a bank line of credit that is drawing dangerously close to full utilization. The Proterra failure looks unlike an SMB failure at first glance because the numbers are so much bigger. Read it again with the doctrine lens on and the mechanism is exactly the same.

Lesson one: Do not run more business lines than your cash pool can independently fund. An SMB owner who runs a service business and a product business and a training business out of the same operating account is running the Proterra mistake at SMB scale. Each of the three has its own working capital requirement. Each has its own cash cycle. Each is competing with the other two for the same working capital reserve. When one of them has a slow quarter, the reserve absorbs the shortfall for all three, and the owner does not see it because the aggregate P&L still looks acceptable. Same mechanism. Different scale.

Lesson two: A capital raise is not operating profit. Proterra treated $640 million in SPAC proceeds as if it were working capital that could fund three growth stories. It was not. It was equity that was being consumed to fund three operating losses. An SMB owner who takes a $50,000 line of credit and treats it as working capital that funds the next six months is making the same mistake. The line is not working capital. It is a borrowed reserve that has to be repaid. Working capital is what the business produces from operating profit, retained in the business, that funds the next operating cycle. If the business is not producing operating profit, the reserve is finite.

Lesson three: Growth without operating profit widens the Gap. Every quarter Proterra grew revenue in 2022, the Working Capital Gap widened because each additional unit of revenue lost money. Growth was not the solution. Growth was the accelerator of the crisis. An SMB owner in a similar position with growing revenue and shrinking cash reserve is running the same pattern. The doctrine reads it before the reserve empties. Nobody in the P&L layer will surface it in time.

Lesson four: Reversal requires focus, not more capital. When Proterra tried to reduce burn in the last 14 months before bankruptcy, the reduction was too small and too late. The intervention that would have worked was choosing one business line and abandoning the other two in 2021. The lesson at SMB scale is that when the reserve is depleting, the answer is not to raise more capital to fund all the business lines that are already draining. The answer is to choose the one business line that is closest to breakeven and abandon the others until that one is self-funding. Then, and only then, consider adding a second line.

Postscript

Proterra as a corporate entity was wound down in March 2024. The three business units were sold to three different buyers between late 2023 and early 2024. Volvo Group acquired Proterra Powered in early 2024 and continues to operate the battery and drivetrain business as part of its heavy vehicle electrification strategy. Phoenix Motor acquired Proterra Transit, keeping the ZX5 platform in production for transit agencies. Marmon Holdings, a Berkshire Hathaway subsidiary, acquired the Proterra Energy charging assets.

Dale Hill, the founder, was 55 when Proterra filed. He had stepped back from executive leadership years before the SPAC and was not directly involved in the 2022 to 2023 cash burn. He watched from outside like the other founders in the archive whose companies grew past their control before failing.

Gareth Joyce, the CEO who filed the Chapter 11 papers, left the company shortly after the sale of the business units. He has taken advisory and board roles in the EV sector since. His public comments have consistently framed the failure as a market timing problem, which is one honest reading. The doctrine reads it as a Working Capital Gap problem that was built into the company's operating model years before the market timing became the trigger.

The Bipartisan Infrastructure Law and the Inflation Reduction Act, which Proterra positioned itself to benefit from, are producing exactly the EV demand curve that Proterra's founders anticipated. Blue Bird, Thomas Built, Nova Bus, and New Flyer are shipping EV buses at growing volumes. The market Proterra bet on exists. Proterra just did not survive to serve it, because the doctrine question about how to fund three business lines out of one cash pool was never asked while there was still time to answer it.

The next SMB owner reading this Autopsy who is running three business lines out of one operating account, or a single business line that is growing revenue while the operating account shrinks, has the same question in front of them that Proterra's board did not answer in 2021. Which business line is closest to self-funding, and can the others be paused, sold, or wound down while the survivor is protected. The doctrine reads the question. The accounting layer will not surface it. Every quarter the question goes unanswered is a quarter of the reserve gone. The clock does not care about the story.

Three business lines cannot all be funded from one cash pool that has no operating profit refilling it. The doctrine reads the mechanism. The accounting layer will not surface it in time.

Proterra ran the Two Cancers spiral in accelerated form for 31 months on $1.6 billion of public-market capital. Return to Owner reads the same mechanism on your actual numbers, at the scale you are actually running, so the question gets answered while there is still time to act.

Find My Leak

The industry you succeeded in does not tell you the industry next door works the same way. The unit economics do not care about your credentials.

Katerra was founded by an operator who had taken Flextronics from $8.5 million to $16 billion in revenue over 13 years. He assumed construction would respond to the same discipline. It did not. Six years later Katerra filed for Chapter 11 with $1.29 billion owed to contractors and cumulative losses of $2.78 billion. Return to Owner reads your Fixed Cost Capacity biomarker against your segment-level gross margins on your actual numbers, so you know before an expansion into a new industry commits your fixed cost base whether the operating discipline you built in your original business is going to produce the same margins in the segment next door, or whether the expansion will quietly kill the standalone business that was healthy before the expansion started.

Find My Leak
Preferred on Google

See more of this work in your Google feed.

Add jayaldebert.com as a Preferred Source. Your Top Stories, Discover, and AI Overviews will surface Aldebert diagnostics ahead of the accountants and coaches trying to sound like them.

Add as Preferred Source